Please note that the contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.
For Investors Relations news and news releases from Fujifilm and FUJIFILM Business Innovation for 2019 and before, please click：
- Jun 29, 2021
- $850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity (Fujifilm)
- Jun 23, 2021
-
Marketing Authorization Granted for Lutathera® Injection in Japan
- The first approval in Japan for peptide receptor radionuclide treatment drug, providing a new therapeutic option for neuroendocrine tumors (FUJIFILM Toyama Chemical) - May 27, 2021
- FUJIFILM Wako Pure Chemical launches “E484Q mutation detection kit” reagent for detecting a SARS-CoV-2 mutation (FUJIFILM Wako Pure Chemical)
- May 18, 2021
- BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases (Fujifilm)
- May 17, 2021
- FUJIFILM Wako Pure Chemical launches mutation detection kit for SARS-CoV-2 “L452R” (FUJIFILM Wako Pure Chemical)
- Apr 27, 2021
- Fujifilm sets its highest record with 23 products winning the internationally prestigious “iF Design Award” (Fujifilm)
- Apr 22, 2021
- Fujifilm launches new app for “instax mini Link” (Fujifilm)
- Apr 21, 2021
- Fujifilm announces the Start of a New Phase III Clinical Trial of Anti-influenza Drug Avigan® Tablet in Japan, Targeting COVID-19 Patients (Fujifilm)
- Apr 15, 2021
- Fujifilm launches a Medium-Term Management Plan, VISION2023
- Apr 15, 2021
- Fujifilm launches FUJINON Lens XF18mmF1.4 R LM WR (Fujifilm)
- Apr 13, 2021
-
Ultra-short throw projector “FUJIFILM PROJECTOR Z8000”
wins the highest-ranked “Best of the Best Award” (Fujifilm)